Find a Programme
UK NEQAS provides External Quality Assessment/Proficiency Testing for all major aspects of clinical laboratory testing. To find the programme(s) to match your EQA/PT requirements please use the search function below.
Showing Results: 196 - 210 out of 431
Hepatitis E detection
|Microbiology
To determine HEV IgM and IgG status in human serum
Hereditary breast and ovarian cancer disorders (HBOC)
|Genomics (GenQA)
Molecular testing for disorders associated with HBOC.
HFE Typing (Scheme 5A)
|Histocompatibility & Immunogenetics
To assess participants' ability to correctly determine HFE mutations
HIT Screening/Assays
|Blood Coagulation
HIV 1 RNA Quantification
|Microbiology
To provide EQA for laboratories determining levels of HIV-1 RNA
HIV Point of Care
|Microbiology
To provide EQA for laboratory and non-laboratory settings that use POCT devices to screen for HIV
HIV Serology
|Microbiology
To provide EQA for laboratories determining HIV status
HLA Antibody Detection (Scheme 6)
|Histocompatibility & Immunogenetics
To assess participants' ability to correctly determine the presence of HLA antibodies using all 'screening' methods the laboratory employs for clinical samples
HLA Antibody Specificity Analysis (Scheme 3)
|Histocompatibility & Immunogenetics
To assess the laboratory's ability to determine the component HLA specificity or specificities in the antisera using all methods the laboratory employs for clinical samples.
HLA Genotyping for Coeliac and other HLA associated diseases (Scheme 8)
|Histocompatibility & Immunogenetics
To assess participants’ ability to correctly determine disease associated HLA allele families/alleles.
HLA Phenotyping (Scheme 1A)
|Histocompatibility & Immunogenetics
To assess participants' ability to use serological and supplementary methods to correctly identify HLA specificities
HLA-B*57:01 Typing for Drug Hypersensitivity (Scheme 7)
|Histocompatibility & Immunogenetics
To assess participants' ability to correctly determine HLA-B*57:01 status
HLA-B27 Testing (Scheme 1B)
|Histocompatibility & Immunogenetics
To assess the participants' ability to correctly determine the HLA-B27/B2708/B*27 status as positive or negative
Holotranscobalamin
|Clinical Chemistry (Birmingham Quality)
Assessment of analytical bias and its consistency across time